SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

SELLAS Life Sciences Closes Public Offering After Full Option Exercise

SELLAS Life Sciences said it closed its underwritten public offering after the underwriters exercised their option to purchase additional shares.

SLS

Related stories